Hear Again

Approximately 37.5 million American adults live with some degree of hearing loss, making it the third most common physical health condition in the United States — yet the overwhelming majority of those individuals go untreated for years before seeking professional care. This gap between the scale of the problem and the penetration of clinical solutions represents one of the most compelling structural opportunities in all of consumer healthcare franchising. Hear Again America was founded in 2013 in Deerfield Beach, Florida, by co-founders Asaf Peled and Dr. Robert Morrison to address exactly this underserved market. Peled, who began his career in hearing health in 2002, brings over two decades of industry-specific operating experience to the franchise model. Dr. Morrison holds a Bachelor of Science, a Master of Arts, and a Doctor of Audiology degree, and brings more than 20 years of proven executive leadership in the hearing aid industry. Together, they built a corporate retail network that exceeded 35 company-owned locations across Florida, Georgia, South Carolina, and Maryland before the company launched its formal franchising program in January 2023. As of 2024, the corporate network encompasses 33 total units, all of which are company-owned, giving the franchise system a strong operational foundation from which to scale. The Hear Again franchise opportunity enters the market at a moment when demographic forces, technological change in hearing device manufacturing, and shifting consumer behavior around preventive health are all converging to create extraordinary tailwinds. This analysis is produced independently by PeerSense and represents original research — not promotional copy generated by or for the franchisor.

The hearing healthcare industry sits at the intersection of two of the most powerful macro forces in consumer services: an aging population and the democratization of medical technology. Globally, 466 million people were living with disabling hearing loss as of 2020, and the World Health Organization projects that figure will exceed 900 million by 2050 — a demographic tide that no policy intervention or competitive dynamic can reverse. In the United States specifically, approximately 10,000 Baby Boomers reach retirement age every single day, and hearing loss prevalence increases sharply with age, affecting roughly one in three adults over 65 and nearly half of all adults over 75. This means the addressable patient population for a hearing healthcare franchise grows larger every day simply through the natural aging of the existing population, with no marketing required to generate demand at the category level. Beyond the aging dynamic, the hearing aid industry itself has been transformed by FDA rulemaking that opened the market to over-the-counter hearing devices in 2022, a change that paradoxically expanded consumer awareness of hearing health while simultaneously increasing demand for professional fitting, programming, and aftercare services that OTC products cannot provide. The competitive landscape for professional hearing healthcare remains highly fragmented, with independent audiologists and small regional chains controlling significant market share alongside a handful of larger retail networks — a fragmentation that creates genuine franchise opportunity for a well-branded, operationally supported system. The combination of inelastic demand driven by an aging population, a widening clinical services gap created by OTC device proliferation, and structural fragmentation in the competitive landscape makes the Hear Again franchise opportunity worthy of serious investor evaluation.

The Hear Again franchise cost structure reflects a mid-tier healthcare retail investment that requires meaningful capital but remains accessible relative to medical clinic formats in adjacent categories. The initial franchise fee is $50,000 for a single Hear Again Center, which is consistent with premium positioning in the hearing health retail segment and reflects the clinical credibility embedded in a brand co-founded by a Doctor of Audiology. Total estimated initial investment ranges from $179,100 to $318,450, with the spread driven primarily by leasehold improvement costs ($25,000 to $75,000), furniture and fixtures ($20,000 to $40,000), and equipment costs ($15,000 to $30,000) — all of which vary significantly based on the condition of the leased space and local construction market pricing. The investment breakdown also includes $20,000 to $28,000 in initial marketing spend, $6,000 to $15,000 for three months of rent and security deposit, $2,000 to $5,000 in travel expenses for initial training, $2,500 to $5,000 in opening inventory and supplies, $2,000 to $5,000 in professional fees, and $30,000 to $50,000 in additional funds to cover the first three months of operations. Ongoing fees include a royalty of 4% of gross sales plus $47.50 per hearing aid dispensed, a structure that partially decouples the royalty from pure revenue and creates a modest per-unit component tied directly to the core product transaction. An advertising or brand fund fee of 12% is also required, which is a notably high marketing contribution relative to many franchise systems and reflects the brand's intention to build regional and national consumer awareness from a relatively early stage in its franchise development. Veterans who have been honorably discharged from the U.S. military may qualify for a 10% discount off the initial franchise fee, bringing that cost to $45,000. For investors seeking to develop multiple locations, area development agreements are available with a minimum commitment of two centers; for example, the right to open three centers carries a total investment range of $249,100 to $388,450. SBA loan eligibility should be explored with a qualified lender given the asset base and franchisor support structure of this model.

The Hear Again franchise operating model is built around a professional retail clinic format that delivers hearing evaluations, hearing aid fittings, and ongoing patient care services. Daily operations center on licensed or certified hearing professionals who conduct diagnostic assessments, recommend and fit hearing devices across multiple price points, and maintain the long-term patient relationships that drive recurring revenue from device reprogramming, maintenance, and replacement. The staffing model for a single center typically requires at minimum one licensed hearing professional and appropriate support staff, and the franchisor mandates that at least one employee complete the initial training program alongside the franchisee. Initial training can be conducted at the corporate office in Boca Raton, Florida, at one of the company's existing corporate-owned retail locations, or at the franchisee's own center — a flexibility that reduces the logistical burden of onboarding. The franchisor reserves the right to require additional or remedial training if service quality falls below established standards, ensuring that brand consistency is maintained across a growing multi-unit system. Ongoing support infrastructure includes an internal marketing team composed of a dedicated graphic designer, a marketing director, and a marketing assistant — all focused exclusively on supporting franchisees with creative assets and data-driven guidance on advertising efficacy. The franchise model is explicitly positioned as turnkey, providing proven operational systems, supply chain relationships, and a clinical brand identity that would take an independent operator many years and significant capital to replicate. Territory protection is structured around a three-mile radius from the approved center location, though in densely populated areas such as central business districts, this radius may be adjusted to a range of two city blocks to three miles. The territory is protected — the franchisor agrees not to establish or authorize a competing Hear Again center within that boundary — though it is not classified as fully exclusive, a distinction that prospective investors should review carefully in the Franchise Disclosure Document.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document, which means the franchisor has elected not to provide a formal financial performance representation to prospective franchisees. This is a material data point for investors, and the absence of a disclosed Item 19 should prompt additional due diligence through direct conversations with existing franchisees, which candidates are legally entitled to conduct using the franchisee contact list provided in the FDD. However, multiple third-party and industry sources provide financial reference points that help contextualize the potential unit economics of a Hear Again franchise investment. One source cites an average unit volume of $530,000, while another reports gross revenue of $644,939 and a third cites yearly gross sales of $1,131,600 — a wide range that likely reflects the difference between a ramp-stage unit, a maturing corporate location, and a top-performing site, respectively. Owner-operator estimated earnings are reported between $147,108 and $181,056 annually, suggesting meaningful income potential for hands-on operators who manage clinical staffing and patient acquisition effectively. Estimated EBITDA figures derived from FDD examples range from $678,560 to $1,821,375, with associated profit margins cited at 18%, 20%, and 33% depending on the unit and revenue scenario — margins that, if validated through franchisee interviews, would represent competitive performance for a healthcare retail concept. The franchise payback period is estimated at between 3.1 and 5.1 years based on available financial modeling, which falls within an acceptable range for a healthcare services investment given the recurring revenue characteristics of the hearing care patient relationship. It is worth noting that the hearing aid industry benefits from high average transaction values — professional hearing aids typically retail between $1,500 and $7,000 per pair — and strong patient retention dynamics, as individuals who invest in hearing solutions tend to return for ongoing care, upgrades, and accessories over a multi-year relationship.

The Hear Again franchise system launched its franchising program in January 2023 and moved quickly, establishing new franchise locations in four territories within less than two months of opening the program to outside investors. The company's geographic footprint reflects a deliberate regional concentration strategy, with the strongest density in Florida — the franchisor's home market — and secondary presence in Georgia, North Carolina, South Carolina, and Virginia. This Southeastern concentration is strategically rational: Florida alone is the third-largest state by population and has one of the highest concentrations of adults aged 65 and older in the nation, making it an ideal proving ground for a hearing health franchise model. The corporate network of over 33 owned locations gives the franchisor operational credibility and allows them to refine systems, test marketing strategies, and validate unit economics before deploying franchise capital — a model that represents a meaningful structural advantage over franchisors who began franchising from a pure concept stage. The co-founder leadership team brings a combined depth of operational and clinical expertise that is rare in franchise systems: Peled's 20-plus years of hearing health business development combined with Dr. Morrison's clinical and executive credentials create a leadership foundation that can speak credibly to both investors and the licensed hearing professionals who will operate these centers. As the franchise system matures past its January 2023 launch, the primary growth levers include new territory awards in under-penetrated Southeast markets, expansion into Mid-Atlantic and Sun Belt states where the target demographic is dense, and the potential for multi-unit development agreements with experienced franchise operators who can accelerate geographic coverage faster than single-unit awards alone.

The ideal Hear Again franchise candidate is an investor who combines business management competence with either a clinical background in hearing health or audiology, or a strong commitment to hiring and retaining qualified licensed hearing professionals. The franchisee model appears best suited to owner-operators who intend to be actively involved in the business rather than purely passive investors, given the clinical service delivery at the core of the business and the patient relationship dynamics that drive recurring revenue. Multi-unit development is explicitly available through area development agreements, and the minimum commitment for such an agreement is two centers, making this an attractive pathway for investors seeking to build a regional hearing health portfolio rather than a single-location operation. Geographic availability is concentrated in the Southeast at present, with Florida, Georgia, the Carolinas, and Virginia representing the core expansion footprint as of the most recent public disclosures, though the brand's January 2023 franchising launch and the scale of the unmet demand nationwide suggest that expansion into additional markets is likely as the system grows. The franchise agreement term length and specific renewal provisions should be reviewed directly in the FDD, as these details govern the long-term capital commitment an investor is making. Prospective candidates should pay particular attention to the protected territory language in their agreement, specifically the distinction between a protected and an exclusive territory, as well as the conditions under which the franchisor can require additional training or remedial action.

The investment thesis for the Hear Again franchise rests on three convergent pillars: a structurally growing addressable market driven by the aging of the Baby Boomer generation and the global rise in hearing loss prevalence; a differentiated brand founded by clinical and operational experts with over 20 years of hearing health experience; and a relatively early franchise development stage that gives incoming franchisees the opportunity to secure preferred territories ahead of broader national expansion. With an initial investment range of $179,100 to $318,450, a $50,000 franchise fee that includes a 10% veteran discount for eligible candidates, and estimated owner earnings that independent sources place between $147,000 and $181,000 annually for owner-operators, the Hear Again franchise opportunity presents a data-supported case for serious due diligence. The absence of an Item 19 financial performance disclosure in the current FDD means that prospective investors carry a higher burden of independent verification — franchisee interviews, market analysis, and competitive benchmarking are not optional steps but essential ones. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to evaluate Hear Again against the full landscape of healthcare and wellness franchise opportunities using standardized, independent metrics. For investors who are serious about allocating capital to the hearing health category — one of the most demographically certain growth markets in American consumer healthcare — independent analysis is the difference between a well-underwritten investment and a costly mistake. Explore the complete Hear Again franchise profile on PeerSense to access the full suite of independent franchise intelligence data.